Clinical Trials Browser

eltrombopag × 1 year × Clear all

NCT03948529 2025-09-30

REGALIA

Phase 2 Terminated

Other hematologic neoplasm

Leukemia

NCT06630221 2025-07-03

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

Phase 2 Recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic